Caliper Life Sciences Inc. is a leading provider of cutting-edge technologies enabling researchers in the life sciences field to create medicines and diagnostic tests more quickly and efficiently. The company’s portfolio of products include state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies and discovery & development outsourcing solutions.
The company announced today it has installed the 1000th IVIS preclinical imaging system, a milestone event in the rapid adoption of Caliper’s proprietary in vivo imaging solutions. The center for Advanced Molecular Imaging at Northwestern University purchased Caliper’s IVIS Spectrum to enable nano-particle technology research for the targeting of cancer tumors and non-invasive monitoring of tumor progression and therapeutic response in patients.
Caliper’s IVIS imaging technology is the leading tool in the rapidly growing field of preclinical non-invasive optical molecular imaging. The use of IVIS technology has assisted in the discovery and development of at least 13 compounds that have moved into clinical testing, 5 of which are FDA-approved treatments.
It is also gained rapid acceptance throughout the pharmaceutical and academic research communities. The company’s preclinical imaging solutions have been a key tool in the generation of more than 2,600 peer-reviewed publications. The research was conducted in a broad range of medical fields including cancer research, cardiovascular disease, toxicology, infectious diseases and stem cells.
For more information about Caliper Life Sciences, please visit the company’s website at www.caliperLS.com
Let us hear your thoughts below:
